We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




RSNA AI Challenge Models Can Independently Interpret Mammograms

By MedImaging International staff writers
Posted on 12 Aug 2025
Image: The AI models detected invasive cancers more accurately than noninvasive ones (Photo courtesy of Shutterstock)
Image: The AI models detected invasive cancers more accurately than noninvasive ones (Photo courtesy of Shutterstock)

Breast cancer screening aims to detect cancers early while minimizing unnecessary recalls, yet balancing sensitivity and specificity remains a challenge. Automating detection in mammograms could help radiologists work more efficiently, improve care quality, and reduce costs. Now, new algorithms have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while maintaining low recall rates.

These algorithms were submitted for the 2023 Screening Mammography Breast Cancer Detection AI Challenge hosted by the Radiological Society of North America (RSNA, Oak Brook, IL, USA). The challenge aimed to source models capable of enhancing cancer detection in screening mammograms and had over 1,500 participating teams from across the world, using a training dataset of around 11,000 images.

Researchers evaluated 1,537 submitted algorithms on 10,830 single-breast exams confirmed by pathology as positive or negative for cancer. The results, published in Radiology, showed a median specificity of 98.7%, sensitivity of 27.6%, and a recall rate of 1.7%. Combining the top three algorithms increased sensitivity to 60.7%, while ensembling the top ten raised it to 67.8%, approaching average screening radiologist performance in Europe or Australia.

The top-performing algorithms complemented each other by identifying different cancers, with thresholds optimized for positive predictive value and specificity. Sensitivity varied by cancer type, imaging equipment manufacturer, and clinical site. The models generally detected invasive cancers more accurately than noninvasive ones, suggesting areas for future optimization.

Many of the submitted models are open source, providing resources for further research and benchmarking. The results could drive improvement in both experimental and commercial AI tools, with the goal of enhancing breast cancer outcomes worldwide. The research team plans to conduct follow-up studies to compare the top algorithms against commercial products using a larger and more diverse dataset.

Follow-up studies will also test performance on smaller, challenging datasets with strong human reader benchmarks, such as those developed by the UK-based PERFORMS scheme. RSNA continues to run its annual AI Challenge, with this year’s competition focusing on detecting and localizing intracranial aneurysms.

"By releasing the algorithms and a comprehensive imaging dataset to the public, participants provide valuable resources that can drive further research and enable the benchmarking that is required for the effective and safe integration of AI into clinical practice," said Yan Chen, Ph.D., lead author of the study.

Related Links:
RSNA

Post-Processing Imaging System
DynaCAD Prostate
X-ray Diagnostic System
FDX Visionary-A
Ultrasound Needle Guidance System
SonoSite L25
Mammo DR Retrofit Solution
DR Retrofit Mammography

Channels

Ultrasound

view channel
Image: The super-resolution lymphatic imaging system could diagnose and monitor patients with lymphatic disease (Photo courtesy of Adobe Stock)

Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time

Lymphatic disorders affect hundreds of millions of people worldwide and are linked to conditions ranging from limb swelling and organ dysfunction to birth defects and cancer-related complications.... Read more

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.